PG-701

DB12252InvestigationalSmall molecule

Hydroxytriptolide has been investigated for the treatment of Rheumatoid Arthritis.

Chemical structure of PG-701
Formula / weight
C20H24O7 · 376.405 g/mol (avg)
Also known as
Hydroxytriptolide · LLDT-8
Code names
J1.909.854K

Resolves to

Compound
UNIIXT5J6G12EHCAS583028-68-6ChEMBLCHEMBL3358841PubChem10317383
Structure
InChIKeyOKRSVUYYCJPECG-LFGMFVMYSA-NSMILESCC(C)[C@]12O[C@H]1[C@@H]1O[C@]11[C@]3(O[C@H]3C[C@@]3(O)C4=C(CC[C@]13C)C(=O)OC4)[C@@H]2O

What you can answer from here — as of June 12, 2020

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of PG-701, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In